Literature DB >> 22770488

Fentanyl (transmucosal).

Robert Twycross1, Eric E Prommer, Mary Mihalyo, Andrew Wilcock.   

Abstract

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22770488     DOI： 10.1016/j.jpainsymman.2012.05.001

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


  3 in total

Review 1.  Management of breakthrough pain in children with cancer.

Authors:  Stefan J Friedrichsdorf; Andrea Postier
Journal:  J Pain Res       Date:  2014-03-07       Impact factor: 3.133

2.  Breakthrough cancer pain and rational drug use.

Authors:  Juan Manuel Núñez Olarte
Journal:  Support Care Cancer       Date:  2017-02-18       Impact factor: 3.603

3.  A randomized controlled trial comparing the effect of intravenous, subcutaneous, and intranasal fentanyl for pain management in patients undergoing cesarean section.

Authors:  Mitra Jabalameli; Reihanak Talakoub; Bita Abedi; Zahra Ghofrani
Journal:  Adv Biomed Res       Date:  2016-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.